SIRT7 Mediated-PTEN Desuccinylation Drives Gastric Tumorigenesis by Activating PI3K/AKT Pathway.
- 1Department of Gastroenterology, Seventh People's Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, China.
- 2Department of General Surgery, Seventh People's Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Abstract
SIRT7 is linked to cancer, yet its function in gastric cancer (GC) remains unclear. PTEN suppresses the PI3K/AKT pathway in GC, its regulation via lysine succinylation and interplay with SIRT7 is unknown. SIRT7 expression was analyzed using TCGA, Human Protein Atlas, clinical samples, and GC cell lines via qRT-PCR, immunoblotting, and immunohistochemistry. SIRT7 was silenced using shRNA, and functional effects were assessed through proliferation, migration, invasion, and xenograft assays. SIRT7-PTEN interaction was validated by co-immunoprecipitation and confocal microscopy, while PTEN stability was examined using cycloheximide chase and mutagenesis. We observed elevated SIRT7 expression in GC, correlating with reduced survival. SIRT7 inhibition markedly impaired tumor growth and metastasis. SIRT7 binds PTEN and desuccinylates it at K322/K330, promoting ubiquitin-mediated degradation. This destabilization of PTEN leads to the activation of the PI3K/AKT signaling pathway. Rescue experiments confirmed that PTEN depletion reverses the tumor-suppressive effects of SIRT7 silencing. Thus, SIRT7 drives gastric carcinogenesis by destabilizing PTEN through site-specific desuccinylation and subsequent activation of the PI3K/AKT axis. This reveals succinylation as a stabilizing modification for PTEN and identifies the SIRT7-PTEN axis as a potential therapeutic target to restore tumor suppression in GC.
Related
- Lycium barbarum polysaccharides alleviate cadmium-induced renal injury in ducks by activating the Nrf2-mediated antioxidant defense pathway.
- Novel androgen receptor N-terminal mutation drives gastric cancer metastasis via YWHAZ-mediated FAK pathway activation
- Leptin receptor deficiency suppresses gastric tumorigenesis by limiting stromal activation and tumor microenvironment development.
- Clemastine alleviates Parkinson’s disease pathology by activating the AMPK/mTOR pathway and enhancing autophagic flux
- Sanguinarine ameliorates rheumatoid arthritis by activating the Hippo-YAP/TAZ pathway to induce apoptosis and suppress inflammation in fibroblast-like synoviocytes
BibTeX
@article{liao2026sirt7,
title = {{SIRT7 Mediated-PTEN Desuccinylation Drives Gastric Tumorigenesis by Activating PI3K/AKT Pathway.}},
author = {Bingling Liao and Sheng Hu and Qilin Zhang and Qihua Xu and Tianning Tian},
journal = {Journal of biochemical and molecular toxicology},
year = {2026},
month = oct,
doi = {10.1002/jbt.71144},
url = {https://europepmc.org/article/MED/42927612},
note = {CC BY-NC},
}
RIS
TY - JOUR
TI - SIRT7 Mediated-PTEN Desuccinylation Drives Gastric Tumorigenesis by Activating PI3K/AKT Pathway.
AU - Bingling Liao
AU - Sheng Hu
AU - Qilin Zhang
AU - Qihua Xu
AU - Tianning Tian
PY - 2026
DA - 2026/10/30
JO - Journal of biochemical and molecular toxicology
DO - 10.1002/jbt.71144
UR - https://europepmc.org/article/MED/42927612
AB - SIRT7 is linked to cancer, yet its function in gastric cancer (GC) remains unclear. PTEN suppresses the PI3K/AKT pathway in GC, its regulation via lysine succinylation and interplay with SIRT7 is unknown. SIRT7 expression was analyzed using TCGA, Human Protein Atlas, clinical samples, and GC cell lines via qRT-PCR, immunoblotting, and immunohistochemistry. SIRT7 was silenced using shRNA, and functional effects were assessed through proliferation, migration, invasion, and xenograft assays. SIRT7-PTEN interaction was validated by co-immunoprecipitation and confocal microscopy, while PTEN stability was examined using cycloheximide chase and mutagenesis. We observed elevated SIRT7 expression in GC, correlating with reduced survival. SIRT7 inhibition markedly impaired tumor growth and metastasis. SIRT7 binds PTEN and desuccinylates it at K322/K330, promoting ubiquitin-mediated degradation. This destabilization of PTEN leads to the activation of the PI3K/AKT signaling pathway. Rescue experiments confirmed that PTEN depletion reverses the tumor-suppressive effects of SIRT7 silencing. Thus, SIRT7 drives gastric carcinogenesis by destabilizing PTEN through site-specific desuccinylation and subsequent activation of the PI3K/AKT axis. This reveals succinylation as a stabilizing modification for PTEN and identifies the SIRT7-PTEN axis as a potential therapeutic target to restore tumor suppression in GC.
SN - 1095-6670
SN - 1099-0461
ER -